WeLeader Biomedical Co., Ltd. (TPEX:7713)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
63.90
+0.20 (0.31%)
Jul 18, 2025, 11:52 AM CST

WeLeader Biomedical Ratios and Metrics

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '25 Dec '24 Dec '23 Dec '22 Dec '21
2,9063,243---
Enterprise Value
3,2453,845---
Last Close Price
63.9073.70---
PE Ratio
16.1419.05---
PS Ratio
2.903.27---
PB Ratio
2.803.57---
P/TBV Ratio
2.813.59---
P/FCF Ratio
24.4630.01---
P/OCF Ratio
10.3611.63---
EV/Sales Ratio
3.243.88---
EV/EBITDA Ratio
10.0715.83---
EV/EBIT Ratio
15.4317.96---
EV/FCF Ratio
27.3135.59---
Debt / Equity Ratio
0.690.880.741.090.79
Debt / EBITDA Ratio
2.202.472.072.301.14
Debt / FCF Ratio
5.977.375.34-1.30
Asset Turnover
-0.530.560.83-
Inventory Turnover
-8.009.7112.54-
Quick Ratio
1.161.040.940.891.13
Current Ratio
1.371.261.121.041.29
Return on Equity (ROE)
17.74%19.41%20.41%30.64%-
Return on Assets (ROA)
-7.18%7.43%9.80%-
Return on Capital (ROIC)
8.17%8.43%8.78%12.24%-
Return on Capital Employed (ROCE)
12.80%14.00%14.90%16.80%25.50%
Earnings Yield
5.75%5.25%---
FCF Yield
4.09%3.33%---
Dividend Yield
5.27%4.57%---
Payout Ratio
57.28%56.18%19.54%6.35%21.14%
Buyback Yield / Dilution
-2.60%-1.55%-35.00%-8.28%-
Total Shareholder Return
2.67%3.02%-35.00%-8.28%-
Source: S&P Global Market Intelligence. Standard template. Financial Sources.